Depletion of both monocyte derived CD163+ macrophages and tissue resident CD163+ Tim4+ macrophages by CD163-targeted lipid nanoparticles loaded with doxorubicin contributed to reduced tumor growth in omentum and reduced metastatic spread in the ascites and to the diaphragm [326] (Figure 3B). The gene discussed is CD163; the disease is neoplasm.